p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.

[1]  E. Schuetz,et al.  p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Roberts,et al.  Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Shoemaker,et al.  Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP. , 1997, Journal of the National Cancer Institute.

[4]  T. Enomoto,et al.  Alteration of p16 and p15 genes in common epithelial ovarian tumors , 1997, International journal of cancer.

[5]  A. Shelling,et al.  Role of p53 in drug resistance in ovarian cancer , 1997, The Lancet.

[6]  A. Hartmann,et al.  The molecular epidemiology of p53 gene mutations in human breast cancer. , 1997, Trends in genetics : TIG.

[7]  M. Volm,et al.  Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB‐1) in childhood acute lymphoblastic leukaemia , 1996, British journal of haematology.

[8]  H. Peterse,et al.  Growth arrest associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR: potential early indicators of treatment response. , 1995, Cancer letters.

[9]  D. Haber,et al.  The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. , 1995, Genes & development.

[10]  T. Akiyama,et al.  WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. , 1994, Blood.

[11]  M. Haber,et al.  Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. , 1994, Cancer research.

[12]  W. Dalton,et al.  Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. , 1994, Cancer research.

[13]  Q. Zhu,et al.  Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. , 1994, Cancer research.

[14]  Amy Bernard,et al.  Physical and functional interaction between WT1 and p53 proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[16]  K. Reiss,et al.  Cyclin D1 messenger RNA is inducible by platelet-derived growth factor in cultured fibroblasts. , 1992, Cancer research.

[17]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[18]  I. Pastan,et al.  Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. , 1992, Science.

[19]  B. Futcher,et al.  Human D-type cyclin , 1991, Cell.

[20]  Richard A. Ashmun,et al.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle , 1991, Cell.

[21]  Koichi Sugimoto,et al.  Mutations of the p53 gene in lymphoid leukemia. , 1991, Blood.

[22]  A. Gazdar,et al.  Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.

[24]  M. Hirose,et al.  Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines. , 1987, British Journal of Cancer.

[25]  I. Pastan,et al.  Multiple-drug resistance in human cancer. , 1987, The New England journal of medicine.

[26]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[27]  M. Hirose,et al.  Two novel cultured cell lines, A3/Kawakami and A4/Fukuda, derived from malignant lymphoma of B(non-T)-cell nature of the gastrointestinal tract. , 1983, Gan.

[28]  S. Collins,et al.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture , 1977, Nature.

[29]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.